This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation.
With the increase in competition, it has become essential for pharmaceutical companies to find the most effective methods of advertisement to reach their target audience. ” New England Journal of Medicine, 2007. The post Effective Pharma Ad Types & Stats appeared first on Pharma Marketing Network. ” U.S.
Pre-competitive collaboration in this space benefits everyone because whether you are a biopharmaceutical company, vendor, publisher or equipment manufacturer, you are invested in ensuring the research ecosystem works seamlessly and drives new breakthroughs. What is your vision for the lab of the future?
For both small biotechs and large pharma, economic uncertainty is rising, intensifying decision-making risks associated with early drug discovery efforts, clinical trials, quality and manufacturing process execution, and navigating the approval process. In 2001 and 2007, through 2009, the economy was hit hard.
After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.
Across swathes of primary care, pharmacological innovation has stalled; the last new antihypertensive class was introduced in 2007 and new antibiotics have trickled in at a dangerously slow pace. To thrive, pharma must ask increasingly tough questions about the viability of candidates for clinical development.
I looked into capital equipment, pharma position, and one more position. I got the pharma position with GSK. This is 2007. You are so spoiled if you are trying to get into this now because there’s competition in this space for you to reach that next level. You need to look into that.” To do referral marketing?
It’s one of the highest earning industries and the most competitive. All the way, ranging from pharma and testing to medical devices and capital equipment, and in this case, aesthetics. I hopped into it in 2007, ’08, and ‘09 when the market crashed but everybody had a cell phone. This is an episode you want to read.
A lot of our readers are trying to get into medical sales, whether it be pharma, medical device, or something in between. It’s the MedTech versus medical devices, and we have the pharma division. I got the invite to go down to headquarters and do a formal interview panel and a great case competition to secure my role.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content